Matrix Metalloproteinase 9 in Nasal NK/T-Cell Lymphoma
Author Information
Author(s): Sakata Koh-ichi, Someya Masanori, Omatsu Mutsuko, Asanuma Hiroko, Hasegawa Tadashi, Hareyama Masato, Himi Tetsuo
Primary Institution: Sapporo Medical University, School of Medicine
Hypothesis
The study investigates the expression of P-glycoprotein and MMP-9 in nasal NK/T-cell lymphoma and their relationship with clinical outcomes.
Conclusion
The strong expression of MMP-9 is characteristic of nasal NK/T cell lymphoma and may contribute to its tendency to metastasize.
Supporting Evidence
- Overall 5-year survival rates for nasal NK/T cell lymphoma were 51%, compared to 84% for nasal non-NK/T cell lymphoma.
- Distant involvement free 5-year survival rates for MMP-9 negative patients were 92%, while for MMP-9 positive patients it was 61%.
- 16 of 19 patients with nasal NK/T cell lymphoma expressed MMP-9.
Takeaway
This study looked at a type of cancer called nasal NK/T-cell lymphoma and found that a protein called MMP-9 is very high in these patients, which might help the cancer spread.
Methodology
Immunohistochemical analysis of P-glycoprotein and MMP-9 expression in biopsy samples from patients with nasal NK/T-cell lymphoma and nasal non-NK/T-cell lymphoma.
Limitations
Results are based on univariate comparisons and should be viewed with caution.
Participant Demographics
20 patients with nasal NK/T cell lymphoma (10 men, 10 women) and 25 patients with nasal non-NK/T cell lymphoma (12 men, 13 women).
Statistical Information
P-Value
0.027
Statistical Significance
p = 0.027
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website